About MPMeditrine s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MPMeditrine s.r.o.
During the past decade, MPMeditrine s.r.o. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
2005-02-01
2014-04-01
Completed
290
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
2005-08-09
2017-05-04
Completed
127
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
2005-12-13
2018-03-11
Completed
79
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
2006-10-01
2012-01-01
Completed
48
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
2005-06-01
2011-04-01
Completed
62
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
2007-05-01
2023-05-01
Active, not recruiting
64
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
2007-06-01
2022-04-18
Completed
200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MPMeditrine s.r.o.
According to Clinical.Site data, the most researched conditions in "MPMeditrine s.r.o." are
"Borderline Personality Disorder" (1 trials), "Depressive Disorder, Major" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "MPMeditrine s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at MPMeditrine s.r.o.
Most popular intervention types in "MPMeditrine s.r.o." are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BI 1358894" (2 trials), "Iclepertin" (1 trials) and "Quetiapine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MPMeditrine s.r.o.
The vast majority of trials in "MPMeditrine s.r.o." are
3 trials for "All" genders.
Clinical Trials Status at MPMeditrine s.r.o.
Currently, there are NaN active trials in "MPMeditrine s.r.o.".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MPMeditrine s.r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MPMeditrine s.r.o., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".